Skip to main content

Our industries

Pharmaceutical, healthcare and life sciences

We are recognised as a leading advisor for patent prosecution and litigation, corporate and licensing work in the pharmaceutical, healthcare and life sciences sectors.

Our pharmaceutical, healthcare and life sciences team stays up-to-date with the rapidly changing landscape of these innovative sectors, advising research institutions, healthcare providers, medical device companies and major pharmaceutical players on the full spectrum of their legal concerns, including regulatory issues such as product registration, clinical trial regulation and marketing authorization applications.

Our IP expertise is designed to protect all aspects of our client’s portfolios. We advise on one-off filings, prosecution and litigation and assist with all aspects of our client’s IP strategies. Our expertise encompasses the full range of patents, trademarks and copyrights. Our clients are prominent international household names with diverse IP portfolios and leading local clients with strong brands nationally and in the region.

We handle various pharmaceutical, healthcare and life sciences advisory work, including compliance, risk management, and dispute resolution. Our experts also regularly defend doctors against malpractice claims, including Medicare/Medicaid and healthcare fraud and abuse. The team benefits from the presence of experienced medical, coding and billing experts.

Practice areas
  • Drugs manufacturing and distribution
  • Product licensing
  • Regulatory compliance
  • Commercial
At a glance
  • Novartis Pharma Pakistan Limited: represented the client in suits and thereafter appeals filed by ex-employees before the District Courts and the High Court of Sindh bench at Larkana.
  • Pakistan Chemists and Druggists Association: represented client and obtained an interim order restraining the operation of section 7 of the import pricing policy as issued by the Drug Regulatory Authority of Pakistan on behalf of the Defending American Life Insurance Company (Pakistan) Limited (ALICO Pakistan) (now known as IGI Life Insurance Limited) and American Life Insurance Company (ALICO) in two suits filed before the High Court of Sindh at Karachi by employees of American Life Insurance Company (Pakistan) Limited, against the intended sale of ALICO’s majority shareholding in ALICO Pakistan, to IGI Insurance Limited.
  • Pfizer Corporation: represented the client in the restructuring and merger of its subsidiaries in Pakistan.
  • Searle IV Solutions: represented client, one of the leading pharmaceutical companies of Pakistan manufacturing lifesaving IV solutions, in a suit relating to whether an S.R.O granting a tax exemption applied to the material imported by Searle.

Speak to lead pharmaceutical, healthcare and life sciences partner Mayhar Kazi today.

Stay in touch

Subscribe to our newsletter

Stay in touch
Sending

News/Insight

  • RIAA Secures Key Win for Textile Industry in Anti-Dumping Investigation

    In a landmark decision, the National Tariff Commission (NTC) terminated a longstanding anti-dumping investigation into polyester filament yarn (PFY) imports from China and Malaysia, marki


    Read more

  • RIAA Barker Gillette ranks high in The Legal 500 Asia Pacific 2025

    We are delighted to share that RIAA Barker Gillette has been recognized as one of Pakistan's leading law firms across several practice areas in the recently released Read more

  • RIAA Advises on Landmark TAPI Pipeline Host Agreement in Afghanistan

    RIAA Barker Gillette has successfully advised TAPI Pipeline Company Limited (TPCL) on the signing of the Host Government Agreement (HGA) for the Herat province segment of the multibillion-dollar Read more

  • Top rankings in Chambers Asia Pacific 2025

    The Chambers Asia-Pacific Guide is widely respected for its thorough evaluation and identification of the leading law firms and lawyers in the Asia-Pacific legal market. Chambers' review of our firm in the 2025 Asia-Paci


    Read more

  • Senior Partner Hasnain Naqvee Shares Insights at Parliamentary IPP Panel

    Hasnain Naqvee, Senior Partner at RIAA Barker Gillette, was invited by the Parliamentary Forum on Energy and Economy to speak at a panel discussion titl


    Read more

What clients say...

  • Chambers Asia Pacific 2022
    "RIAA are responsive, professional and polite in explaining their advice, well researched in their opinions, and reliable in their response time… they also share commercial and operational consequences of the options presented in their advice. We are very happy with their support…." - Chambers Asia Pacific 2022

  • The Legal 500 2022
    “RIAA has an excellent litigation practice that advises on the full range of contentious issues as well as international arbitrations. The practice regularly handles all forms of civil, commercial, corporate, regulatory and white-collar crime matters before all the courts in Pakistan. It has extensive experience in a diverse range of industry sectors …” – The Legal 500 2022

  • Chambers Asia Pacific 2022
    "We find them to be extremely professional and responsive. They are meticulous in raising all the right legal points but at the same time are very solution-oriented in helping to structure the transactions in the right way to fully protect our legal rights." – Chambers Asia Pacific 2022

  • The Legal 500 2022
    “The team has an excellent track record of working on some of the most significant projects in Pakistan throughout the years.” – The Legal 500 2022 

  • Legal 500 2021
    We have worked with RIAA Barker Gillette for many years on a number of matters, including regulatory issues, labor, general corporate, competition law, and tax matters…..We have found high-quality lawyers across disciplines, who are able to balance the requirement for technically sound advice while also being practical and solution-orientated - Legal 500 2021

Read more